Welcome Guest | Register / Login

Pharmaceuticals Market Research Reports

The global pharmaceutical market has persistently experienced significant growth due to the ever-increasing demand for novel and more effective drugs. The reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth, newer and more complex disease conditions, ageing population, and the increased prevalence of chronic and infectious diseases, some of which still remain incurable and fatal. Such numerous unmet needs and high demand rates have triggered the boost in R&D investments by key industry sectors, greatly driving the growth of this i... View more

Sort By
Title Published Price Buy Now
United States Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: The US pharmaceutical market presents strong commercial opportunities across the industry. Total US pharmaceutical sales reached USD347.2bn in 2013 - more than three times the size of its nearest rival Japan. The US boasts the l...
Sep 2014 $ 1295
Slovenia Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: Slovenia is facing deflationary pressures on consumer prices, which will impact pharmaceutical spending - especially as an increasing proportion of high-value drugs is met by co-payments. We have therefore downwardly revised our...
Sep 2014 $ 1295
Myanmar Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: While the current medical gap will attract some foreign investors into Myanmar, we highlight that the lack of basic infrastructure and political instability will potentially affect the growth of the economy. Headline Expen...
Sep 2014 $ 1295
Kazakhstan Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: Kazakhstan's healthcare sector suffers from a lack of trained medical professionals and the inherent difficulties of providing infrastructure and access to healthcare in such a large country. However, the government continues to...
Sep 2014 $ 1295
Ireland Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: The US government and the OECD recent proposals to discourage corporate inversion pose downside risk to the rate of M&A deals that opt to establish their new headquarters' domicile in Ireland, although the megatrend of consolida...
Sep 2014 $ 1295
Iran Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: BMI continues to adjust its forecasts for Iran's pharmaceutical market to account for the sanction-induced currency crisis and high rates of inflation. The rapid depreciation of the rial means that we expect the value of the mar...
Sep 2014 $ 1295
Central America Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: Costa Rica and Panama will continue to outperform other Central American countries, namely El Salvador, Guatemala, Honduras, Nicaragua and Belize. The business-friendly environment, high percapita medicine spending and strong co...
Sep 2014 $ 1295
Bangladesh Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: We consider Bangladesh's commitment to another round of spending on the development of healthcare, information technology, infrastructure, energy production, education, agriculture and food security and transportation in fiscal ...
Sep 2014 $ 1295
Austria Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: BMI has upwardly revised its pharmaceutical and healthcare forecasts for Austria, reflecting the country's improving economic prospects and attractiveness of these sectors in particular. The United States Commerce department has...
Sep 2014 $ 1295
Tolvaptan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot s...
Sep 2014 $ 600
Elvitegravir - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot s...
Sep 2014 $ 600
Simeprevir - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot s...
Sep 2014 $ 600
Tolvaptan - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot s...
Sep 2014 $ 1400
Elvitegravir - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot s...
Sep 2014 $ 1400
Simeprevir - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot s...
Sep 2014 $ 1400
Ticagrelor - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot s...
Sep 2014 $ 600
Paliperidone - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot s...
Sep 2014 $ 600
Fosaprepitant - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot s...
Sep 2014 $ 600
Enzalutamide - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot s...
Sep 2014 $ 600
Aprepitant - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot s...
Sep 2014 $ 600
Ticagrelor - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot s...
Sep 2014 $ 1400
Paliperidone - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot s...
Sep 2014 $ 1400
Fosaprepitant - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot s...
Sep 2014 $ 1400
Enzalutamide - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot s...
Sep 2014 $ 1400
Aprepitant - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot s...
Sep 2014 $ 1400
Live Chat
Live Chat by Comm100